Healthcare reform is on the lips of every 2008 Presidential hopeful. Take a look beyond the lip service and examine the platforms of Democratic and Republican front-runners.
As a result, Democratic and Republican candidates are rolling out health reform platforms that promise to cover the uninsured while also retaining choice. There is much talk of "shared responsibility" between the government, industry and consumers for expanding access to care, and little enthusiasm for abandoning the employer-based insurance system in favor of a single-payer, government-run plan.
Democrats
Republicans
Health reform is a lower priority issue for Republican voters, who are wary of big government programs and higher taxes. Instead of expanding federal services, Republicans look to boost coverage by offering tax credits and deductions that make it easier for individuals to purchase insurance.
Even former Massachusetts Governor MITT ROMNEY, who helped engineer that state's health reform initiative, shies away from talk of expanding federal programs and mandating coverage.
Insurers
For insurers and health plans, broader healthcare coverage could expand the health insurance market. Subsidies and tax incentives, as well as coverage mandates, promise to increase the number of covered lives and to give patients more resources to pay their bills. Democratic plans "could be very good for insurers because we would see more people covered," explains Sandy Lutz, managing director of PricewaterhouseCoopers' Health Research Institute.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More